Created in 1997 (United States), Metabasis Therapeutics own 8 sister brands and 2214 competing brands. Metabasis Therapeutics is owned by Ligand Pharmaceuticals, listed on the stock exchange of New York Metabasis Therapeutics belongs to the Biotechnology business sector.

Metabasis Therapeutics is a brand of Ligand Pharmaceuticals (LGND) Share price

Date created : 1997 Business sector Biotechnology

Share price and profitability of the share Ligand Pharmaceuticals (Metabasis Therapeutics)

Buy Ligand Pharmaceuticals share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 72.47

Portfolio valuation
Ligand Pharmaceuticals (Metabasis Therapeutics) over 5 years* USD 64.81

Stock market history Ligand Pharmaceuticals (Metabasis Therapeutics)

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Ligand Pharmaceuticals

LIGAND
LIGAND
See more brands of Ligand Pharmaceuticals

Rival brands
Metabasis Therapeutics

NOTABLE LABS
NOTABLE LABS
Roivant
Roivant
Valerio Therapeutics
Valerio Therapeutics
INVERSAGO
INVERSAGO
Terns Pharma
Terns Pharma
Vaxcyte
Vaxcyte
OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking
Desirable brands that generate Pricing Power and therefore stock market performance
Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more
MORE NEWS